Lupin & EAU Successfully Conclude Masterclass ‘Best Of EAU19’

Pharma major Lupin Limited (Lupin) has successfully concluded the third edition of its series of medical symposiums for the Indian urology community. The latest edition, titled Masterclass: Best of EAU19, was organised in collaboration with the European Association of Urology (EAU) across four cities – Mumbai, New Delhi, Chennai and Kolkata- from December 18-22, 2019 and saw an impressive turnout of 550 urologists in attendance. It also marked the second consecutive year of Lupin’s collaboration with the EAU for organising the Masterclass.

This Masterclass leveraged the best of the Annual EAU Congress and enabled discussions around the latest clinical practices and key innovations in the field of urology. It also acquainted urology practitioners in India with the advancements made globally in this field and shared ideas to apply new best practices for patients in India.

Speakers at the event included globally renowned specialists such as Prof. Christopher Chapple from Sheffield U.K., an expert in functional urology; Prof. Marko Babjuk from Charles University, Prague, Cezch Republic; Prof. Maarten Albersen, Assistant Professor and adjunct head of clinic in Urology, University Hospitals Leuven; and Prof. Nikolaos Grivas, Netherlands Cancer Institute, Department of Urology.

Shares of LUPIN LTD. was last trading in BSE at Rs.766.25 as compared to the previous close of Rs. 754.15. The total number of shares traded during the day was 86240 in over 2550 trades.

The stock hit an intraday high of Rs. 770 and intraday low of 752.2. The net turnover during the day was Rs. 65657367.-Equity Bulls